- Article
Association between Dapagliflozin, Cardiac Biomarkers and Cardiac Remodeling in Patients with Diabetes Mellitus and Heart Failure
- Andrew Xanthopoulos,
- Nikolaos Katsiadas,
- Spyridon Skoularigkis,
- Dimitrios E. Magouliotis,
- Niki Skopeliti,
- Sotirios Patsilinakos,
- Alexandros Briasoulis,
- Filippos Triposkiadis and
- John Skoularigis
Sodium–glucose cotransporter-2 inhibitors (SGLT2is) are a relatively new class of antidiabetic drugs that have shown favorable effects in heart failure (HF) patients, irrespective of the left ventricular ejection fraction (LVEF). Recent studies...

